Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood

Abstract

Late mortality among children undergoing allogeneic BMT has decreased during the past 3 decades. However, these patients remain at an elevated risk of late mortality even 25 years or more after transplantation when compared with the general population, necessitating lifelong follow-up.